Graphical abstract
Differential expression of vitamin D-associated enzymes and receptors in brain cell subtypes

Introduction
For the past two decades, vitamin D has been increasingly recognized as a potent neurosteroid with multiple actions in the brain (1, 2) . Based on the well-described endocrine actions of vitamin D, it is metabolized to its hormonal form 1,25(OH)2D3 in various organs such as the gut and kidney and, in this form, it enters the brain via the blood brain barrier to act directly on cells containing its nuclear receptor, the vitamin D receptor (VDR) (3).
However, it appears now also likely that an autocrine/paracrine system within the nervous system underlies the cerebral actions of vitamin D in brain. In the latter case, the presence of the various key enzymes and receptors is a prerequisite.
A number of studies have acknowledged the presence of enzymes and receptors across different brain regions and within the various cerebral cell types (4, 5, 6, 7, 8, 9) . Although there is evidence for VDR presence in the mammalian brain, there is still some dispute about the cellular and subcellular localization of this receptor within the nervous system. This debate is in part based on the work by DeLuca's group claiming the absence of VDR protein in the brain, questioning the technical tools at our disposal (10) . In a recent study, we provide unambiguous evidence, using mass spectrometry, that VDR is present in the rodent brain, however it is in significantly lower amounts than in reference tissues such as the gut and kidney (11) .
Although several studies demonstrated the presence of VDR and/or certain enzymes in various cell-types of the nervous system, no single study compared the relative expression of VDR, CYP450 enzymes CYP27a1, CYP27b1 and CYP24a1 among all these cell types.
Protein disulfide isomerase family member3 (PDIA3), also known as 1,25 D3-MARRS or ER57, was identified as a membrane receptor of vitamin D (12) . Given the relatively low abundance of VDR in the brain it may be possible that a membrane receptor plays a more important role in vitamin D signaling in this organ.
No study so far has examined the cellular distribution of metabolic enzymes and receptors in the brain. This is crucial in understanding the nature of vitamin D processing and action in this tissue. Ideally, fractionation of brain tissues followed by mass spectrometry would help with this issue. However, given the extremely low amounts of VDR previously shown to be present, this approach would require extremely high amounts of starting material.
We therefore decided to analyze transcript expression in cultured individual brain cells (astrocytes, endothelial cells, microglia, neurons, oligodendrocytes) of enzymes and receptors implicated in vitamin D metabolism.
Materials and methods
Organ collection
Livers, kidneys, cortex and hippocampus were collected from three adult Wistar rats and frozen at -80°C before being used for RNA extraction and qPCR.
Primary cell cultures
Neurons
Cells were prepared from the cerebral cortex or hippocampus of E18 Wistar rats, as previously described (13) . Briefly, embryos were placed on ice and their brains were quickly removed aseptically. Blood vessels and meninges were discarded. Cerebral cortices and hippocampi were collected separately in Hanks' balanced salt solution, dissociated with trypsin and plated at a density of 1.2x10 5 cells/cm 2 on poly L-lysine coated coverslips.
Neurons were cultured in Neurobasal medium supplemented with 2% B-27, 1% penicillinstreptomycin, and 0.3% glutamine in a humidified atmosphere containing 5% CO2 at 37°C for 2 weeks. Cells were then exposed to 20 nM 1,25(OH)2D3 or 20 nM EtoH as a vehicle for 12 hours prior to RNA extraction (see below).
Astrocytes
Astrocytes were prepared from 2-day old newborn rat cerebral cortices, as described before (14) . After removal of the meninges, the brain tissue was dissociated with trypsin. Dissociated glial cells were seeded into cell culture flasks and the culture medium (Dulbecco's Modified
Eagle's Medium supplemented with 10% fetal bovine serum, 100 units/mL antibiotic penicillin, and 100 μg/mL streptomycin) was replaced three times a week. After 1 week of proliferation, the glial cells were gently shaken for 24 hours to remove the microglial cells. 
Oligodendrocytes
Oligodendrocytes were prepared as previously described (16) . Briefly, cortical precursors were isolated from E15.5. Oligodendrocyte precursors were enriched in serum-free oligodendrocyte growth medium supplemented with bFGF (20ng/ml) and PDGF-AA. Cells were then cultured in oligodendrocyte differentiation medium without mitogens for 10 days before treatment and collection. 
RNA extraction
Total RNA was isolated from the purified cell types using RNeasy Mini kit (Qiagen, Courtaboeuf, France), according to the manufacturer's instructions. RNA concentration was determined using a Nanodrop 2000 spectrophotometer (Life Technologies ThermoFisher Scientific, Villebon sur Yvette, France) and RNA integrity assessed on an Agilent 2100
Bioanalyzer (Agilent Technologies, Les Ulis, France).
qPCR
Reverse transcription was performed on 1g of RNA using the high capacity RNA-to-cDNA mix (applied biotechnologies). qPCR was performed on 25ng of cDNA using the following primers: 
Statistical analysis
All baseline inter-organ and inter-cell type data were analyzed by Anova test followed by the Least significant difference (LSD) post-hoc test. For the experiments based on the addition of 1,25(OH)2D3 in the culture medium, the cell type-based pairwise comparisons were performed using the Wilcoxon test.
Results
Quantitative comparison of gene expression was performed by comparing the expression of the gene of interest to two housekeeping genes, namely Hprt (hypoxanthine-guanine phosphoribosyltransferase) and beta actin. Quantification with both reference genes provided similar results and we report here the data obtained with the gene whose level of expression was closer to those of vitamin D-associated genes, that is Hprt.
Hprt was expressed at very similar levels in every organ and every cell subtype, including cells cultivated with 1,25(OH)2D3.
Transcripts coding for vitamin D-associated enzymes and VDR are less abundant in brain tissue but Pdia3 is highly expressed.
As expected the expression of Cyp450 enzymes relevant to vitamin D metabolism were less abundant in the brain compared to classic vitamin D target organs. This was also the case for the Vdr. Interestingly, the expression of Pdia3 was greater in the brain, when compared to the two other organs (Fig. 1) .
Neurons are equipped to transform cholecalciferol and 25(OH)D3 into 1,25(OH)2D3
As shown on Figure 2 , the transcripts coding for CYP27a1, CYP27b1 and CYP24a1 were comparatively highly expressed in neurons. Overall, Cyp27a1 was expressed in every cell type, with a high expression in endothelial cells. However, Cyp27b1 and Cyp24a1 transcript expression was close to zero in astrocytes, oligodendrocytes and endothelial cells. Microglia were in intermediate position with a consistent but not elevated expression of the three enzymes. Figure 2 indicates that the overall expression of the transcript coding for the VDR was very limited in all cell types, except in astrocytes. Conversely, Pdia3 mRNA was present in relative abundance in every brain cell subtype and peaked in endothelial cells.
Vdr is expressed mostly in astrocytes but Pdia3 is present in every cell type
1,25(OH)2D3 treatment induces a very limited effect on Vdr and Pdia3 expression
In order to assess a putative effect of 1,25(OH)2D3 on the vitamin D machinery-associated transcripts, we measured their expression after a 12 hour-treatment. Figure 3 shows that Vdr and Pdia3 expression was unaffected by a short term addition of 1,25(OH)2D3 in the culture medium, except in microglia and endothelial cells where a statistically significant modification was observed for Vdr and Pdia3, respectively. In regard to the enzymes, only the expression of Cyp24a1 transcript was increased but only in astrocytes and microglia.
Discussion
The current study is the first to exhaustively assess the cellular expression of genes coding for vitamin D-associated metabolic enzymes and receptors, at the level of the neuro-vascular unit.
It now requires to be confirmed at the protein level and in the brain. However, our data allow the protein CYP27b1 is found in human neurons (7) and ii) cultured murine microglia can metabolize 25(OH)D3 to 1,25(OH)2D3 (9) . Noticeably, the current study reports a very weak expression of Cyp27b1 in astrocytes and oligodendrocytes, suggesting that these cells are less likely to produce 1,25(OH)2D3, unlike what was observed in one of our previous studies, based on protein detection using immuno-histochemistry (7). Nevertheless, it should be borne in mind that our work is exclusively based on mRNA expression and it cannot be excluded that the CYP27b1 protein, produced by neurons or microglia, is transferred to glia.
We report here that the astrocytes are the predominant cell type expressing the transcript coding for the vitamin D receptor and therefore appear to be the most likely cell type to respond to 1,25(OH)2D3 at the genomic level. The presence and functionality of VDR in astrocytes is also backed up by another major finding: these cells undergo important increases in Cyp24a1 after 1,25(OH)2D3 treatment. It is established that vitamin D and its receptor induce the expression of CYP24a1 (17), in a dose-dependent manner (4). Interestingly, CYP24a1 has been observed previously in rat glia cells (4) and in astrocytes of the human brain (18) . However, the latter study also reported the presence of CYP24a1 in human neurons, a finding that is not confirmed by our work at the transcriptomic level. Such a discrepancy could potentially be explained by differential immunohistochemical response to certain antibodies.
We also show here that the expression of Vdr transcript remains steady when 1,25(OH)2D3 is added to the culture medium. This observation is coherent with previous in vivo studies indicating that VDR transcription in adult animals is not affected by a prenatal vitamin D depletion (19, 20) or supplementation during adulthood (21). However, a slightly different picture emerges when looking at mouse newborns that grew in the womb of vitamin Ddeficient mothers. We found that Vdr mRNA is overexpressed in their spinal cord at birth (22) .
Similarly, inflammation may trigger the transcription of VDR and Cyp27b1, as demonstrated in an in vitro study (23) Although well studied in various cell systems (24, 25) , very little is known about PDIA3 expression in the nervous system. It has been reported that this vitamin D receptor mediates the action of diosgenin, a plant-derived steroidal sapogenin, which induces cognitive enhancement in normal mice (26) and a reduced number of amyloid plaques and neurofibrillary tangles in a mouse model of Alzheimer's disease (27) . In line with this, the current study is the first to report that Pdia3 is highly expressed in the brain, when compared 
